Connection

William Hrushesky to Drug Approval

Back to Details
This is a "connection" page, showing publications William Hrushesky has written about Drug Approval.
William Hrushesky
Connection Strength
0.809
Drug Approval
  1. Interpretation of surrogate endpoints in the era of the 21st Century Cures Act. BMJ. 2016 Dec 30; 355:i6286.
    View in: PubMed
    Score: 0.524
  2. Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions. Lancet Oncol. 2020 12; 21(12):e575-e588.
    View in: PubMed
    Score: 0.172
  3. Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. 2014 Dec; 15(13):e594-e605.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.